Farson; Deborah A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Farson; Deborah A..The latest application filed is for "method and means for producing high titer, safe recombinant lentivirus vectors".

Company Profile

0.14.5

Farson; Deborah A. - Oakland CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method and means for producing high titer, safe recombinant lentivirus vectors Grant 8,846,385 - Naldini , et al. September 30, 2	2014-09-30
Method and means for producing high titer, safe, recombinant lentivirus vectors Grant 8,652,837 - Naldini , et al. February 18, 2	2014-02-18
Method And Means For Producing High Titer, Safe Recombinant Lentivirus Vectors App 20080286836 - Naldini; Luigi ; et al.	2008-11-20
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells Grant 7,252,991 - Finer , et al. August 7, 2	2007-08-07
Method and means for producing high titer, safe, recombinant lentivirus vectors Grant 7,083,981 - Naldini , et al. August 1, 2	2006-08-01
Method and means for producing high titer, safe, recombinant lentivirus vectors App 20050255597 - Naldini, Luigi ; et al.	2005-11-17
Method and means for producing high titer, safe, recombinant lentivirus vectors Grant 6,924,144 - Naldini , et al. August 2, 2	2005-08-02
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells App 20030199093 - Finer, Mitchell H. ; et al.	2003-10-23
Method and means for producing high titer, safe, recombinant lentivirus vectors App 20020173030 - Naldini, Luigi ; et al.	2002-11-21
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells App 20020106799 - Finer, Mitchell H. ; et al.	2002-08-08
Method and means for producing high titer, safe, recombinant lentivirus vectors Grant 6,428,953 - Naldini , et al. August 6, 2	2002-08-06
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells Grant 6,218,187 - Finer , et al. April 17, 2	2001-04-17
Method and means for producing high titer, safe, recombinant lentivirus vectors Grant 6,165,782 - Naldini , et al. December 26, 2	2000-12-26
Method and means for producing high titer, safe, recombinant lentivirus vectors Grant 5,994,136 - Naldini , et al. November 30, 1	1999-11-30
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells Grant 5,858,740 - Finer , et al. January 12, 1	1999-01-12
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells Grant 5,834,256 - Finer , et al. November 10, 1	1998-11-10
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells Grant 5,686,279 - Finer , et al. November 11, 1	1997-11-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.